NDC11 65628020605
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65628-0206-05 | 65628-0206 |
| 65628-0206-5 | 65628-0206 |
| 65628-206-05 | 65628-206 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FIRVANQ | VANCOMYCIN HYDROCHLORIDE | Azurity Pharmaceuticals, Inc | 5aca5508-b577-446c-9980-ab4c7582b4b9 | 2026-07-14 | Warnings, Adverse reactions | 65628-206-05 65628-206 65628020605 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.